Point-of-Care Whole Blood Impedance Aggregometry Versus Classical Light Transmission Aggregometry for Detecting Aspirin and Clopidogrel: The Results of a Pilot Study

BACKGROUND:We determined whether whole blood impedance aggregometry using the Multiplate® detects the effects of antiplatelet drugs as reliably as does classical light transmission aggregometry (LTA) or the platelet function analyzer PFA-100®. METHODS:Multiplate (M) assays, measuring changes in electrical resistance as aggregation units over time (AU*min), and LTA assays induced by collagen (COL), adenosine diphosphate (ADP) or arachidonic acid (AA) and PFA-100 testing, using epinephrine (PFA100-EPI) or ADP (PFA100-ADP) cartridges, were performed simultaneously using arterial blood samples obtained before induction of anesthesia in 70 consecutive patients scheduled for elective coronary artery bypass grafting. Patients in group A (n = 48) served as controls, patients in group B (n = 11) received aspirin 100 mg/d and those in group C (n = 11) aspirin 100 mg/d and clopidogrel 75 mg/d until the day before surgery. RESULTS:In controls the median (1st, 3rd quartiles) change in impedance AU*min for M-COL (374 [231–469]) was significantly greater than in patients receiving aspirin (164 [86–211], P = 0.0009) or receiving aspirin and clopidogrel (118 [101–244], P = 0.004). M-ADP values in controls were 258 (158–389), in patients receiving aspirin 261 (159–393), and in patients receiving aspirin and clopidogrel 88 (48–231, P = 0.054). M-AA values were significantly lower in patients receiving aspirin alone (45 [28–60], P = 0.0004) or aspirin and clopidogrel (44 [26–221], P = 0.008) than in controls (200 [86–345]). The areas under the receiver operating characteristic curves indicating the ability to discriminate patients taking aspirin from those not taking aspirin were comparable for COL and AA assays using whole blood impedance aggregometry or classical LTA (M-COL 0.84 [P = 0.001], LTA-COL 0.85 [P = < .001], M-AA 0.84 [P = < .001] and LTA-AA 0.87 [P = < .001]), but only 0.74 for PFA-100-EPI (P = 0.03). Similarly, for discrimination of patients not taking antiplatelet drugs from patients taking clopidogrel and aspirin the areas under the receiver operating characteristic curve were also comparable for both aggregometry methods M-COL 0.77 (P = 0.006), LTA-COL 0.78 (P = 0.004), M-ADP 0.74 (P = 0.015), LTA-ADP 0.73 (P = 0.018). CONCLUSION:Results achieved with the bedside Multiplate assays were not different than those obtained with classical aggregometry for detecting the effects of aspirin and clopidogrel in preoperative patients scheduled for elective cardiac surgery.

[1]  D C Cardinal,et al.  The electronic aggregometer: a novel device for assessing platelet behavior in blood. , 1980, Journal of pharmacological methods.

[2]  Andrew J. Johnson,et al.  Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood , 2005, Platelets.

[3]  Stefan Moritz,et al.  Accuracy of Cerebral Monitoring in Detecting Cerebral Ischemia during Carotid Endarterectomy: A Comparison of Transcranial Doppler Sonography, Near-infrared Spectroscopy, Stump Pressure, and Somatosensory Evoked Potentials , 2007, Anesthesiology.

[4]  M. Eugster,et al.  The influence of the haematocrit on primary haemostasis in vitro , 2005, Thrombosis and Haemostasis.

[5]  S. Harder,et al.  Avoidance of Bleeding During Surgery in Patients Receiving Anticoagulant and/or Antiplatelet Therapy , 2004, Clinical pharmacokinetics.

[6]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[7]  E. Favaloro.  Clinical application of the PFA-100® , 2002, Current opinion in hematology.

[8]  S. Yusuf,et al.  Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial , 2004, Circulation.

[9]  C. Macaya,et al.  Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. , 2007, Journal of the American College of Cardiology.

[10]  M. Silver,et al.  A Quick Method for Screening Platelet Dysfunctions Using the Whole Blood Lumi-Aggregometer , 1984, Thrombosis and Haemostasis.

[11]  A. Kastrati,et al.  Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment , 2007, Thrombosis and Haemostasis.

[12]  M. Behan,et al.  Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1. , 2004, Cell calcium.

[13]  P. Corso,et al.  Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache? , 2005, European heart journal.

[14]  Paul J. Harrison,et al.  Measuring antiplatelet drug effects in the laboratory. , 2007, Thrombosis research.

[15]  P. Hellstern,et al.  Can platelet function tests predict the clinical efficacy of aspirin? , 2005, Seminars in thrombosis and hemostasis.

[16]  Paul J. Harrison,et al.  Platelet function analysis. , 2005, Blood reviews.

[17]  K. Zou,et al.  Receiver-Operating Characteristic Analysis for Evaluating Diagnostic Tests and Predictive Models , 2007, Circulation.

[18]  E. Salzman,et al.  Synergism of platelet-aggregating agents. Role of elevation of cytoplasmic calcium. , 1987, The Journal of clinical investigation.

[19]  T. Mueller,et al.  Monitoring Aspirin 1 00 mg and Clopidogrel 75 mg Therapy with the PFA-1 00 Device in Patients with Peripheral Arterial Disease , 2003 .

[20]  H. Mani,et al.  Response to aspirin and clopidogrel monitored with different platelet function methods , 2006, Platelets.

[21]  R. Wunderink,et al.  Effect of clopidogrel on bleeding after coronary artery bypass surgery , 2001, Critical care medicine.

[22]  R. Hongo,et al.  The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass grafting , 2002 .

[23]  A. Nurden,et al.  Procoagulant activity and active calpain in platelet-derived microparticles. , 1996, Thrombosis research.

[24]  M. Packham,et al.  Platelet function assays. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[25]  P. Steg,et al.  Myocardial infarction after aspirin cessation in stable coronary artery disease patients. , 2000, International journal of cardiology.

[26]  E. Frenkel,et al.  Approach to the Assessment of Platelet Function: Comparison between Optical-based Platelet-rich Plasma and Impedance-based Whole Blood Platelet Aggregation Methods , 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[27]  P. Théroux,et al.  Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug. , 2005, Journal of the American College of Cardiology.

[28]  M. Ray,et al.  Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.

[29]  P. R. R. Ecurrent,et al.  EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .

[30]  Kevin P. Bliden,et al.  Clopidogrel for Coronary Stenting Response Variability, Drug Resistance, and the Effect of Pretreatment Platelet Reactivity , 2003, Circulation.

[31]  R. Hongo,et al.  The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. , 2002, Journal of the American College of Cardiology.

[32]  Peter Hellstern,et al.  Variables influencing Multiplate™ whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals , 2007, Platelets.

[33]  O. Pradier,et al.  Does the platelet function analyser (PFA-100) predict blood loss after cardiopulmonary bypass? , 2003, British Journal of Anaesthesia.

[34]  E. Topol,et al.  A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. , 2003, Journal of the American College of Cardiology.

[35]  J. Smith,et al.  Evaluation of electrical aggregometry: comparison with optical aggregometry, secretion of ATP, and accumulation of radiolabeled platelets. , 1983, The Journal of laboratory and clinical medicine.

[36]  W. Siess,et al.  Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood , 2006, Thrombosis and Haemostasis.

[37]  W. Vaughn,et al.  Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. , 2004, The Journal of thoracic and cardiovascular surgery.

[38]  P. Southern,et al.  Whole-blood platelet aggregation predicts in vitro and in vivo primary hemostatic function in the elderly. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[39]  G. Chatellier,et al.  A Study of Platelet Functions with a New Analyzer Using High Shear Stress (PFA100™) in Patients Undergoing Coronary Artery Bypass Graft , 2000, Thrombosis and Haemostasis.

[40]  G. Geroulakos,et al.  The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease , 2004, Platelets.

[41]  Andrew J. Johnson,et al.  Adenine nucleotide metabolism in human blood – important roles for leukocytes and erythrocytes , 2005, Journal of thrombosis and haemostasis : JTH.

[42]  U. Budde.  Diagnose von Funktionsstörungen der Thrombozyten mit Hilfe der Aggregometrie/Diagnosis of Platelet Function Defects with Platelet Aggregometers , 2002 .

[43]  W. Nichols,et al.  Variability in clinical laboratory practice in testing for disorders of platelet function , 2005, Thrombosis and Haemostasis.

[44]  S. Mallett,et al.  Quantifying the Effect of Antiplatelet Therapy: A Comparison of the Platelet Function Analyzer (PFA-100®) and Modified Thromboelastography (mTEG®) with Light Transmission Platelet Aggregometry , 2006, Anesthesiology.

[45]  G. Born,et al.  The aggregation of blood platelets , 1963, The Journal of physiology.

[46]  P. Gurbel,et al.  Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. , 2005, Journal of the American College of Cardiology.